Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iBeat was a health technology company that developed a life-saving heart-monitoring smartwatch designed to detect sudden cardiac arrest and other heart-related emergencies. The device continuously monitored a user's heart rate and, upon detecting a life-threatening issue, would automatically alert the user, their emergency contacts, and a 24/7 dispatch center. Founded by Ryan Howard, the company aimed to bridge the gap between fitness trackers and medical-grade emergency response systems. iBeat's technology integrated cellular connectivity and GPS to ensure help could be dispatched to the user's exact location. The company was acquired by 100Plus in 2020 to bolster its remote patient monitoring capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iBeat.